ACCURAY INCORPORATED Fair Value Adjustment of Warrants
ACCURAY INCORPORATED (ARAY) reported Fair Value Adjustment of Warrants of -$8.37 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-27.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-27
- ACCURAY INCORPORATED fair value adjustment of warrants for the quarter ending 2026-06-30 was -$1.17M, a 334.67% decline year-over-year.
- ACCURAY INCORPORATED fair value adjustment of warrants for the quarter ending 2026-03-31 was -$3.36M.
- ACCURAY INCORPORATED fair value adjustment of warrants for the quarter ending 2025-12-31 was -$5.71M.
- ACCURAY INCORPORATED fair value adjustment of warrants for the quarter ending 2025-09-30 was $1.87M.
- ACCURAY INCORPORATED fair value adjustment of warrants for fiscal 2026 was -$8.37M, a 1777.15% decline from fiscal 2025.
- ACCURAY INCORPORATED fair value adjustment of warrants for fiscal 2025 was $499.00K.
- ACCURAY INCORPORATED fair value adjustment of warrants for fiscal 2024 was $0.00.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27 | -$4.53M derived: sum of 2 quarters · filed 2026-08-27 | -$10.24M derived: sum of 3 quarters · filed 2026-08-27 | -$8.37M 10-K · filed 2026-08-27 |
| 2026-03-31 | -$3.36M 10-Q · filed 2026-05-06 | -$9.07M derived: sum of 2 quarters · filed 2026-05-06 | -$7.20M 10-Q · filed 2026-05-06 | -$6.70M derived: sum of 4 quarters · filed 2026-08-27 |
| 2025-12-31 | -$5.71M 10-Q · filed 2026-02-17 | -$3.84M 10-Q · filed 2026-02-17 | -$3.34M derived: sum of 3 quarters · filed 2026-08-27 | -$3.34M derived: sum of 4 quarters · filed 2026-08-27 |
| 2025-09-30 | $1.87M 10-Q/A · filed 2026-02-17 | $2.37M derived: sum of 2 quarters · filed 2026-08-27 | $2.37M derived: sum of 3 quarters · filed 2026-08-27 | $2.37M derived: sum of 4 quarters · filed 2026-08-27 |
| 2025-06-30 | $499.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27 | $499.00K derived: sum of 2 quarters · filed 2026-08-27 | $499.00K derived: sum of 3 quarters · filed 2026-08-27 | $499.00K 10-K · filed 2026-08-27 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-05-06 | $0.00 10-Q · filed 2026-05-06 | |
| 2024-12-31 | $0.00 10-Q · filed 2026-02-17 | $0.00 10-Q · filed 2026-02-17 | ||
| 2024-09-30 | $0.00 10-Q/A · filed 2026-02-17 | |||
| 2024-06-30 | $0.00 10-K/A · filed 2026-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |